These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Serum osteocalcin in children with chronic renal insufficiency]. Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853 [TBL] [Abstract][Full Text] [Related]
8. Calcium metabolism in patients with acute renal failure. Mautalen CA; Von der Walde F; Firmat J Medicina (B Aires); 1974; 34(5):507-16. PubMed ID: 4437389 [No Abstract] [Full Text] [Related]
9. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism]. Motz W Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325 [TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
11. [Bone collagen metabolism in uremia--studies of plasma hydroxyproline level in chronic, non-dialyzed kidney disease]. Heidbreder E; Lüke F; Heidland A Verh Dtsch Ges Inn Med; 1975; 81():971-4. PubMed ID: 1229629 [No Abstract] [Full Text] [Related]
12. Reevaluation of the usefulness of serum free hydroxyproline as a parameter for assessing renal osteodystrophy. Uehara H Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):49-58. PubMed ID: 8336400 [TBL] [Abstract][Full Text] [Related]
13. [Selected parameters of bone metabolism in hemodialyzed and peritoneally dialyzed patients]. Małyszko J; Zbroch E; Wołczyński S; Myśliwiec M Przegl Lek; 2000; 57(12):711-3. PubMed ID: 11398592 [TBL] [Abstract][Full Text] [Related]
15. The evaluation of bone changes in patients with rheumatoid arthritis. Perlík F; Kůtová M Z Rheumatol; 1983; 42(5):261-4. PubMed ID: 6649934 [TBL] [Abstract][Full Text] [Related]
16. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms. Radom S; Zulawski M; Golebiowska D Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776 [No Abstract] [Full Text] [Related]
17. [Secondary oxalosis in chronic renal insufficiency]. Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142 [TBL] [Abstract][Full Text] [Related]
18. Biochemical picture of bone metabolism in breast cancer patients with bone metastases. Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881 [TBL] [Abstract][Full Text] [Related]
19. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728 [TBL] [Abstract][Full Text] [Related]
20. Correlation of serum parathormone level with biochemical parameters in chronic renal failure. Rahman MH; Hossain MM; Sultana S; Jamal CY; Karim MA Indian Pediatr; 2005 Mar; 42(3):250-4. PubMed ID: 15817973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]